Lab Corp. (LH) Tops Q2 EPS by $1.58, Revenues Beat

Go back to Lab Corp. (LH) Tops Q2 EPS by $1.58, Revenues Beat

Lab Corp. (LH) Receives FDA Emergency Use Authorization for COVID-19 Sample Pooling

July 25, 2020 12:04 PM EDT

LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced it received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) permitting diagnostic testing of groups of individuals for active COVID-19 infections... More